Antigen-specific Immune Response to Hepatitis B Virus in Utero
NCT00845403 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2014-01-13
Summary
This study aims to gain an understanding of the key components of the immune response to hepatitis B present in cord blood of HBV infected mothers.
Conditions
Sponsors & Collaborators
-
National University Hospital, Singapore
lead OTHER
Principal Investigators
-
Yap Seng Chong, MBBS · National University Hospital, Singapore
Eligibility
- Min Age
- 21 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-09-30
- Primary Completion
- 2016-12-31
- Completion
- 2016-12-31
Countries
- Singapore
Study Locations
More Related Trials
-
Predictive Model for Prognosis of Chronic HBV Infection Mothers
NCT04805034 ·Status: UNKNOWN
-
Quantification of Binding and Neutralizing Antibody Levels in COVID-19 Vaccinated Health Care Workers Over 1 Year
NCT04910971 ·Status: UNKNOWN
-
The Immune Responses After Hepatitis B Revaccination Doses in a Young Cohort
NCT04970836 ·Status: RECRUITING ·Phase: NA
-
Maternal Antiviral Treatment and Infants Immunoprophylaxis in the Prevention of Mother-to-child Transmission
NCT03977987 ·Status: COMPLETED
-
HBsAb Response After HBV Vaccination in Chronic Hepatitis B Patients Who Have Lost HBsAg
NCT03405597 ·Status: UNKNOWN ·Phase: PHASE3
-
Activation of Hepatitis B Virus (HBV) in Hepatitis B Surface Antigen (HBsAg) - Negative But Hepatitis B Core Antibody (Anti-HBc) - Positive Patients
NCT00881036 ·Status: COMPLETED
-
Immunogenicity of the Hepatitis B Vaccine
NCT04540653 ·Status: UNKNOWN ·Phase: PHASE4
-
Dose of Hepatitis B Vaccines in Non/Low-response Populations
NCT01564134 ·Status: COMPLETED ·Phase: NA
-
Seroepidemiologic Study of Spermatozoal Transmission of Hepatitis B Virus (HBV)
NCT01574521 ·Status: COMPLETED
-
The Immunogenicity and Persistence of Booster Dose With Hepatitis B Vaccine in College Students
NCT05099757 ·Status: UNKNOWN ·Phase: PHASE4
-
Antibody Response and Immune Memory 15-18 Years After HBV Vaccination
NCT00172328 ·Status: UNKNOWN ·Phase: NA
-
Studies of Immune Responses in Patients With Chronic Hepatitis B
NCT00155155 ·Status: COMPLETED
-
Risk of Hepatitis Flare in Patients With Previous Hepatitis B Virus Exposure Amongst Patients
NCT04356404 ·Status: TERMINATED
-
Efficacy of Hepatitis B Vaccine Boosters Among Neonatally Vaccinated Children in Chongqing
NCT03867643 ·Status: RECRUITING
-
Hepatitis B Virus Infection in Immunized Children With HBsAg-positive Parents
NCT03864263 ·Status: UNKNOWN
-
Impact of Hepatitis B Vaccination on HBs Antigenemia
NCT03193775 ·Status: COMPLETED ·Phase: NA
-
Seroprevalence of Hepatitis B Infection and Effect of Booster Response Amongst Taiwanese Young Adults
NCT00702663 ·Status: UNKNOWN
-
The Hepatitis B Vaccine Booster Response Among the Youth Who Had Completed Neonatal Hepatitis B Vaccines
NCT00792610 ·Status: COMPLETED ·Phase: NA
-
Sustained Viral Response in Patients Achieved HBsAg Level≤100 IU/ml After Completed Interferon Treatment
NCT02348502 ·Status: UNKNOWN
-
Antibody Response to COVID-19 Vaccines in Liver Disease Patients
NCT04775069 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of the Interruption on the Mother-to-child Transmission of Hepatitis B Virus （HBV MTCT）in Newborns at High Risk
NCT02901418 ·Status: UNKNOWN
-
HBV DNA Levels During Pregnancy in Chronic Hepatitis B
NCT01610115 ·Status: UNKNOWN
-
Generation of Anti-HCV Antibodies From Bone Marrow: Defining the Repertoire of Immune Response to HCV Quasispecies
NCT00004851 ·Status: COMPLETED
-
Immunogenicity Study of an Inactivated Hepatitis A Vaccine in Infants and Young Children
NCT00139113 ·Status: COMPLETED ·Phase: PHASE4
-
Predictive Value of HBV pgRNA on Long-term Outcomes in Hepatitis B Patients Treated With Antiviral Therapy
NCT05965388 ·Status: NOT_YET_RECRUITING